Delivery Order SPE2DB20D1100-SPE2DB24FD2W3

Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 250 MG CAPSULE 100S, a pharmaceutical product, with a firm fixed price of $1,197.32 and a completion date of May 19, 2025. The contract is not set aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $3,404.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of 100 units of the prescription medication CellCept 250 mg capsules. The delivery order has a completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a large $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CellCept 500 mg tablets, a medication used to prevent organ rejection in transplant patients. The contract has a firm fixed price of $2,407.68 and a completion date of May 16, 2025. It is not set aside for any particular socioeconomic program. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4565134752 units of CellCept 500 mg tablets. The $7,967.40 firm fixed price contract has a ceiling value and an ultimate completion date of July 15, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,758.80 firm fixed-price contract is for the delivery of 4,568,078,056 units of the medication CellCept 250 mg capsules by April 30, 2025. The award is not designated as a set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,177,785 units of the medication CellCept 500 mg tablet in 500-count containers. The contract has a firm fixed price of $33,780.80 and a performance period ending on May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 250 MG CAPSULE 100S, a prescription medication, with a firm fixed price and a ceiling value of $8,997.00. The contract has an ultimate completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 100S, a medication used to prevent organ rejection in transplant patients. The contract has a ceiling value of $3,472.08 and a completion date of June 24, 2025. The contract is not set-aside, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a ceiling value of $10,535.87 and a completion date of May 20, 2025. The contract is a Firm Fixed Price contract and is not set aside for any specific small business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a firm fixed price of $6,014.65 and a performance period ending on July 7, 2025. The contract is not set aside and was awarded on July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD2W3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of CellCept 250 mg capsules, a pharmaceutical product used in transplant patients. The contract has a firm fixed price of $6,400.61 and an ultimate completion date of August 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/14/24, 9:11 AM